ABVC BioPharma
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $1 | $1 | $389 |
Gross Profit | -80 | -113 | 1 | 388 |
EBITDA | -2,294 | -607 | 92 | |
EBIT | -2,375 | -720 | 85 | |
Net Income | -2,257 | -842 | 229 | -186 |
Net Change In Cash | 0 | 1 | 1 | 389 |
Free Cash Flow | -894 | -539 | -493 | 171 |
Cash | 388 | 152 | 248 | 137 |
Basic Shares | 17,386 | 14,968 | 13,137 | 12,405 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $509 | $152 | $969 | $355 |
Gross Profit | 508 | -150 | 683 | 350 |
EBITDA | -4,343 | -6,331 | -15,197 | -10,972 |
EBIT | -4,543 | -6,711 | -15,220 | -10,983 |
Net Income | -4,903 | -7,788 | -16,423 | -12,839 |
Net Change In Cash | 509 | 152 | 969 | 355 |
Free Cash Flow | -1,809 | -4,257 | -7,518 | -7,615 |
Cash | 248 | 60 | 85 | 5,828 |
Basic Shares | 11,674 | 4,336 | 3,166 | 2,505 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.13 |
2025-03-31 | $0.02 |
2024-09-30 | -$0.01 |
2024-06-30 | -$0.08 |
